You just read:

Actinium Pharmaceuticals Highlights Analysis of Pivotal Iomab-B Phase 3 SIERRA Trial Presented in Oral Session at ASH Annual Meeting

News provided by

Actinium Pharmaceuticals, Inc.

Dec 04, 2018, 08:00 ET